Neutralizing Antibodies

Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

BACKGROUND: More than two years into the COVID-19 pandemic, most of the population has developed anti-SARS-CoV-2 antibodies from …

María-Eugenia Zaballa, Javier Perez-Saez, Carlos De Mestral, Nick Pullen, Julien Lamour, Priscilla Turelli, Charlène Raclot, Hélène Baysson, Francesco Pennacchio, Jennifer Villers, Julien Duc, Viviane Richard, Roxane Dumont, Claire Semaani, Andrea Jutta Loizeau, Clément Graindorge, Elsa Lorthe, Jean-François Balavoine, Didier Pittet, Manuel Schibler, Nicolas Vuilleumier, François Chappuis, Omar Kherad, Andrew S. Azman, Klara M Posfay-Barbe, Laurent Kaiser, Didier Trono, Silvia Stringhini, Idris Guessous, Specchio-COVID19 Study Group

Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination

BACKGROUND: Immunity after SARS-CoV-2 infection or vaccination has been threatened by recently emerged SARS-CoV-2 variants. A …

Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, Ruijia Sun, Wanying Lu, Nan Zheng, Jiaxin Zhou, Qianhui Wu, Xiaowei Deng, Zeyao Zhao, Xinghui Chen, Shijia Ge, Juan Yang, Daniel T Leung, Hongjie Yu